ARTICLE;
ECONOMICS;
FORECASTING;
HEALTH CARE COST;
HEALTH ECONOMICS;
HUMAN;
INFORMATION PROCESSING;
MEDICAID;
MEDICARE;
NURSING HOME;
ORGANIZATION AND MANAGEMENT;
PRESCRIPTION;
STATISTICAL ANALYSIS;
STATISTICS;
UNITED STATES;
ACTUARIAL ANALYSIS;
DATA COLLECTION;
ECONOMICS, HOSPITAL;
FORECASTING;
HEALTH EXPENDITURES;
HUMANS;
MEDICAID;
MEDICARE;
NURSING HOMES;
PRESCRIPTIONS, DRUG;
PRIVATE SECTOR;
PUBLIC SECTOR;
UNITED STATES;
House Document 107-54 Washington: U.S. Government Printing Office
It is assumed that there will be no new legislation or changes to current legislation affecting Medicare or Medicaid. 2001 Annual Report of the Board of Trustees of the Federal Hospital Insurance Trust Fund, House Document 107-54 (Washington: U.S. Government Printing Office, 2001); and 2001 Annual Report of the Board of Trustees of the Federal Supplementary Medical Insurance Trust Fund, House Document 107-53 (Washington: GPO, 2001).
It is assumed that there will be no new legislation or changes to current legislation affecting Medicare or Medicaid. 2001 Annual Report of the Board of Trustees of the Federal Hospital Insurance Trust Fund, House Document 107-54 (Washington: U.S. Government Printing Office, 2001); and 2001 Annual Report of the Board of Trustees of the Federal Supplementary Medical Insurance Trust Fund, House Document 107-53 (Washington: GPO, 2001).
For descriptions of the national health expenditures projections models, see S. Smith et al., "The Next Decade of Health Spending: A New Outlook," Health Affairs (July/Aug 1999): 86-95; and Centers for Medicare and Medicaid Services, "Projections of National Health Expenditures: Methodology and Model Specification," 〈www.hcfa.gov/stats/nhe-proj/proj2001/Methodology〉 (available 12 March 2002).
For descriptions of the national health expenditures projections models, see S. Smith et al., "The Next Decade of Health Spending: A New Outlook," Health Affairs (July/Aug 1999): 86-95; and Centers for Medicare and Medicaid Services, "Projections of National Health Expenditures: Methodology and Model Specification," 〈www.hcfa.gov/stats/nhe-proj/proj2001/Methodology〉 (available 12 March 2002).
IMS Health, "IMS Health Reports U.S. Pharmaceutical Promotional Spending Reached Record $13.9 Billion in 1999," 20 April 2000, 〈www.ims.health.com/public/structure/dispcontent/1,2779,1203-1203-75077,00. html〉 (27 December 2001).
